Fig. 2From: Bisphosphonates as disease-modifying drugs in osteoarthritis preclinical studies: a systematic review from 2000 to 2020Quality assessments of the preclinical studies based on the Animals in Research Reporting In Vivo Experiments (ARRIVE) guidelines. Values are expressed by frequencies (%)Back to article page